DBV Technologies Correlations

DBVT Stock  USD 20.78  1.98  10.53%   
The current 90-days correlation between DBV Technologies and Annexon is 0.02 (i.e., Significant diversification). The correlation of DBV Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

DBV Technologies Correlation With Market

Good diversification

The correlation between DBV Technologies and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DBV Technologies and DJI in the same portfolio, assuming nothing else is changed.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DBV Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.
For more information on how to buy DBV Stock please use our How to Invest in DBV Technologies guide.

Moving together with DBV Stock

  0.78VERA Vera TherapeuticsPairCorr
  0.64DRUG Bright Minds BiosciencesPairCorr
  0.78DXB DimerixPairCorr
  0.670P6S Bayer AG NAPairCorr
  0.73VNDA Vanda PharmaceuticalsPairCorr

Moving against DBV Stock

  0.7CMB Cambium BioPairCorr
  0.52DRMA Dermata TherapeuticsPairCorr
  0.45JUMP Leveljump Healthcare CorpPairCorr
  0.38VCEL Vericel Corp OrdPairCorr
  0.37RAC Race OncologyPairCorr
  0.31AVH Avita MedicalPairCorr
  0.69PYC Physiomics PlcPairCorr
  0.55VIVS VivoSim Labs Symbol ChangePairCorr
  0.48SABSW SAB BiotherapeuticsPairCorr
  0.44DWTX Dogwood TherapeuticsPairCorr
  0.42DTIL Precision BioSciencesPairCorr
  0.73VTGN VistaGen TherapeuticsPairCorr
  0.58VSTM VerastemPairCorr
  0.57CDTTW Conduit PharmaceuticalsPairCorr
  0.57BSFA BSF Enterprise PlcPairCorr
  0.48VRAX Virax Biolabs GroupPairCorr
  0.42MRVL Marvel Biosciences CorpPairCorr
  0.37EDSA Edesa BiotechPairCorr
  0.33ALA Arovella TherapeuticsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LBRXANNX
ENGNANNX
LBRXENGN
AMRNKRRO
LXEOLRMR
CLLSANNX
  

High negative correlations

CLLSKRRO
LBRXAMRN
KRROANNX
AMRNANNX
ANROAMRN
LBRXKRRO

Risk-Adjusted Indicators

There is a big difference between DBV Stock performing well and DBV Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DBV Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
LRMR  3.46 (0.32) 0.00  0.48  0.00 
 6.58 
 21.85 
ANNX  4.30  1.49  0.27 (0.39) 3.32 
 11.30 
 35.10 
ALT  3.23  0.27  0.02 (0.22) 4.49 
 7.35 
 33.75 
KRRO  5.06 (0.83) 0.00  0.35  0.00 
 8.00 
 91.55 
ENGN  4.48  0.53  0.05 (0.23) 4.97 
 6.77 
 61.40 
AMRN  2.12 (0.44) 0.00 (3.58) 0.00 
 3.33 
 20.43 
ANRO  5.80  1.80  0.31  0.50  5.34 
 11.36 
 100.99 
LXEO  3.76 (0.11) 0.00  0.15  0.00 
 7.04 
 34.26 
CLLS  3.58  0.43  0.04 (0.16) 4.12 
 9.24 
 29.31 
LBRX  3.55  0.51  0.09 (0.80) 3.46 
 9.38 
 23.59 

DBV Technologies Corporate Management

Jonathan NeelyVP RelationsProfile
PharmD DChief OfficerProfile
Joseph BeckerVP CommunicationsProfile
Sbastien RobitailleChief OfficerProfile
Wence AgbotounouChief Clinical Trial OfficerProfile
Caroline DaniereChief StaffProfile